Results 41 to 50 of about 47,373 (236)

Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: A meta-analysis [PDF]

open access: yes, 2009
Background: We present a systematic review and meta-analysis of the available clinical trials concerning the usefulness of aripiprazole in the treatment of the psychotic symptoms in bipolar disorder.Methods: A systematic MEDLINE and repository search ...
A Cipriani   +52 more
core   +2 more sources

Aripiprazole sensitizes head and neck cancer cells to ionizing radiation by enhancing the production of reactive oxygen species

open access: yesPharmacology Research & Perspectives, 2022
Drug repositioning is an alternative process for drug development in cancer. Specifically, it is a strategy for the discovery of new antitumor drugs by screening previously approved clinical drugs.
Hyeon‐Jeong Jeong   +6 more
doaj   +1 more source

A 12-month follow-up study of treating overweight schizophrenic patients with aripiprazole [PDF]

open access: yes, 2008
Objective: To investigate the feasibility of switching overweight schizophrenic patients to aripiprazole and to assess the impact of 12 months of aripiprazole treatment on weight in routine practice.
Bruggeman, R.   +6 more
core   +2 more sources

A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells

open access: yesAnticancer Research, 2021
Background/Aim: We investigated drugs that could sensitize P-glycoprotein (P-gp)-overexpressing drug-resistant cancer cells to vincristine (VIC) or eribulin treatment and assessed their associated mechanisms of action.
Chunxue Jiang   +8 more
semanticscholar   +1 more source

Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders [PDF]

open access: yes, 2019
Objective To systematically evaluate the efficacy of treatments for tics and the risks associated with their use. Methods This project followed the methodologies outlined in the 2011 edition of the American Academy of Neurology\u27s guideline development
Cavanna, Andrea E   +12 more
core   +2 more sources

Antipsychotics drug aripiprazole as a lead against breast cancer cell line (MCF-7) in vitro

open access: yesPLoS ONE, 2020
Breast cancer is the second leading cause of death among women globally. The existing treatment options for breast cancer are largely associated with severe toxicities, and lower efficacies.
A. Badran   +7 more
semanticscholar   +1 more source

Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan

open access: yesTherapeutic Advances in Psychopharmacology, 2022
Background: Aripiprazole is a third-generation antipsychotic agent with acceptable efficacy and a good safety profile. Previous studies have indicated the therapeutic serum concentration of aripiprazole to be 100 to 350 ng/ml; however, most of these ...
Yun Tien   +3 more
doaj   +1 more source

Patterns of management of patients with dual disorder (psychosis) in Italy: a survey of psychiatrists and other physicians focusing on clinical practice [PDF]

open access: yes, 2018
© 2018 Clerici, de Bartolomeis, De Filippis, Ducci, Maremmani, Martinotti and Schifano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).Patients with severe psychotic disorders such as ...
Acquas   +39 more
core   +4 more sources

Antipsychotic switching in bipolar disorders: a systematic review. [PDF]

open access: yes, 2017
With the increasingly widespread use of antipsychotics in bipolar disorder (BD), switching among these agents and between antipsychotics and mood stabilizers has become more common, in particular, since the introduction of the novel atypical ...
Bernardo Arroyo, Miquel   +5 more
core   +4 more sources

Aripiprazole

open access: yesReactions Weekly, 2006
europepmc   +2 more sources

Home - About - Disclaimer - Privacy